Introduction
Biliary excretion is a major elimination pathway for many drugs and/or their metabolites, and has significant impact on exposure, pharmacological and toxicological effects of drugs (Gregus and Klaassen, 1987; Fagerholm, 2008) . Estimating its contribution to the total systemic clearance is thus extremely valuable for predicting clinical pharmacokinetics and understanding the possible mechanisms of hepato-biliary toxicity and potential drug-drug interactions (Lave et al., 2009) . Many in vitro and in situ tools have been established to understand the hepato-biliary disposition of drugs. However, limited information exists on the ability of these models to predict human biliary disposition, primarily, due to the absence of systematic clinical studies measuring the rate and extent of biliary elimination of drugs (Roberts et al., 2002; Ghibellini et al., 2006; Lave et al., 2009) . Therefore, despite the species differences and potential difficulties in extrapolating biliary excretion, the bile-duct cannulated (BDC) rat model is often used for assessing biliary elimination (Yang et al., 2009; Luo et al., 2010) . Unfortunately, this model is less amenable for generating data for large number of compounds to support drug design efforts in the discovery setting due to time-consuming and complicated protocols. Consequently, a computational model for predicting rat biliary excretion could significantly reduce laboratory efforts and expedite decision process (Yang et al., 2009; Chen et al., 2010; Luo et al., 2010) .
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The samples were quantified using quadruple mass spectrometer. LC/MS/MS analysis was conducted on a Sciex Triple Quad 400 mass spectrometer (turbospray ionization source) with a Shimadzu LC-10 HPLC system and Gilson 215 autosampler. The mass spectrometer was controlled by Analyst 1.4.2 software. Triplicate aliquots of each sample of bile and plasma were transferred to a vial and were precipitated usually with 20 volumes of methanol containing an appropriate internal standard. The samples were vortex-mixed and centrifuged. The supernatant was analyzed using LC/MS/MS methodology with conditions optimized and validated for individual compound. When radiolabeled material was available for quantification, triplicate gravimetric aliquots of each sample of bile and plasma were mixed with liquid scintillation cocktail (10 ml for bile and 5 ml for plasma) and counted for 2 min in a model LS 6000 or LS 6500 liquid scintillation counter (Beckman Coulter, Fullerton, CA).
The percentage of biliary excretion (%BE) was calculated based on the intravenous Human OATPs (hOATP1B1, hOATP1B3, and hOATP2B1) expressed in human embryonic kidney 293 (HEK 293) cells were obtained from Prof. Dietrich Keppler (DKFZ, Heidelberg, Germany). Rat Oatp1b2 (rOatp1b2) expressed in the Chinese Hamster Ovary (CHO) cells were provided by Prof. Peter Meier (University of Zurich, Switzerland). Cell culture and assay conditions used for these three major hepatic hOATPs and the rOatp1b2 substrate assays were described previously (Kalgutkar et al., 2007) . Briefly, transporter-expressing or vector-transfected HEK293 cells were seeded onto 24-well poly-D-lysine-coated plates at a density of ∼ 2.5x10 5 cells per well and grown for 3 days. After the cells were confluent, they were washed three times with 1 mL uptake buffer. The transporter substrate assay was initiated by incubation of the cells with 250 μ L of compound (1μM and 10μM) for 2 min at 37°C. At completion of incubation, uptake was stopped by washing the cells three times with ice-cold buffer. The cells were then lyzed in 1:1 methanol:water mixture containing internal standard, and processed for LC/MS/MS analysis. The hOATP1B1, hOATP2B1, hOATP1B3 and rOatp1b2
substrates estradiol 17β-D-glucuronide, estrone 3-sulfate, bromosulpothalin and rosuvastatin, respectively, were used as quality control for uptake studies. Compounds were considered to be substrate of a transporter when the uptake ratio (uptake by transporter-transfected cells/uptake by vector-transfected cells) was ≥ 2.0.
Literature rat biliary excretion/clearance and OATP transporters substrate datasets
A total of 163 rat biliary excretion and 48 rat biliary clearance data points were directly taken from the recent compilation by Yang et al. (Yang et al., 2009) . Data for all drugs or compounds in this dataset were obtained following intravenous administration in BDC rats. The list of 97 drugs or compounds, which were reported in the literature as substrates of hOATP transporters (OATP1B1, OATP1B3 and OATP2B1) was retrieved from the University of Washington database (www.druginteractioninfo.org, accessed on 10 th March, 2011) .
Calculated physicochemical properties
This article has not been copyedited and formatted. The final version may differ from this version. Properties including molecular weight (MW), calculated n-octanol/water partition coefficient (cLogP, ACD), calculated n-octanol/water distribution coefficient (cLogD7.4, ACD), polar surface area (PSA Å 2 , ACD), number of free rotatable bonds (RB) and number of hydrogen bond donors (HBD) and acceptors (HBA) were obtained using an in-house program.
The relative polar surface area (%RPSA = PSA/MW*100) and relative rotatable bonds (%RRB = RB/MW*100) were also calculated. Passive transcellular permeability was calculated using an in-house model developed based on more than 70,000 compounds in the training set, and published elsewhere (Gupta et al., 2010) .
Binary classification and Receiver Operating Characteristic (ROC) curve analysis
ROC curve analysis was used to define property cut-off for high rat BE and test the predictability of the obtained cut-off value. The ROC curve depends on the calculation of sensitivity and specificity (Bewick et al., 2004; Martinez-Bauer et al., 2006) . The area under the curve (AUC) of a ROC curve can be used as a diagnostic of the performance of the test. In general, an AUC value larger than or equal to 0.8 is usually regarded as acceptable (Strik et al., 2001 ). When ROC curve did not yield a point with both sensitivity and specificity above 0.8, an arbitrary cut-off was assigned to the value that showed sensitivity of 0.8. For obtaining property cut-off, we defined rat BE greater than or equal to 10% as true positives and BE less than 10% as true negatives.
In silico model for rat biliary excretion
A binary classification model was built using the Gradient Boosting Machine (GBM) regression and 183 MOE 2D descriptors. The GBM regression is an in-house implementation of the method described by Friedman et a. (Friedman, 2001 at 10% BE. The predictability of this model was assessed via a 5-fold cross validation approach. In this approach, the data was sorted by activity (% biliary excretion) and every 5 th compound was selected for a test set while the remaining 80% was used to build the model. This process was repeated 5 times, with a different 20% selected at each time. Ultimately, 5 models were built and every compound was part of a test set.
A scoring function model for biliary excretion
Using cut-offs values derived from ROC analysis (Table 3) , we build a scoring function based on three determinants -MW, PSA, acidic pKa (Martinez-Bauer et al., 2006) . For MW and PSA, an increasing linear monotonic function was used with the limits set at 300 to 400 and 80 to 120, respectively. For the acidic pKa, a decreasing linear monotonic function was used with the limit at 6.4 and 8.4. Each score ranges from 0.1 -1. The individual scores are summed.
Thus for example, a compound with a MW < 300, PSA < 80 and acid pKa > 8.4 would have a summed score of 0.3. Conversely, a compound with MW > 400, PSA > 120 and acid pKa < 6.4
would have a summed score of 3. Compounds with determinant values between these ranges would have a score between 0.3 and 3. A ROC analysis was then performed on the summed scores and %BE. An AUC of 0.847 was obtained and the cutoff value was determined to be a score of 2.1.
Statistics
Standard statistical tests were used to analyze the differences in the pharmacokinetic parameters and physicochemical properties of various data subsets. The parametric t-test (unpaired, 2-tailed, unequal variance) was employed to determine the significance. However, data was also analyzed by the nonparametric Mann-Whitney test (2-tailed), as the distributions of some properties are skewed away from normality (Varma et al., 2009; Varma et al., 2010b) .
This article has not been copyedited and formatted. The final version may differ from this version. 
Results

Physicochemical space of rat biliary excretion
The dataset (Supplemental Table 1 ) ) was mined for trends between physicochemical properties and rat %BE values. The ionization state distribution of the compounds that showed BE in rat suggested that about 60% of the compounds showing %BE≥10 of intravenous dose are acids (Figure 1a ). The mean %BE of acids (36%) is more than two fold higher (p<0.01) than that of other ionization states (Fig. 1B) . Furthermore, above the mean value of rat %BE of all acids (%BE=36) only about 27% of compounds are non-acids (bases, neutrals and zwitterions).
No distinct differences were noted in the distribution and mean BE for bases, neutrals and zwitterions.
Since acids are predominantly excreted in bile, the whole dataset was further divided to acids (n=116) and non-acids (n=170) subsets for further trend analysis. In general, no single physicochemical property could be considered uniquely predictive of %BE. Nevertheless, trends were noted in which mean %BE values showed significant relationship with MW, cLogD7.4, PSA, number of rotatable bonds and Andrews' binding energy ( Fig. 2A , Table 1 and Table 2 ).
On average, MW, polar descriptors (PSA, RPSA, and hydrogen bond count), number of rotatable bonds and Andrews' energy increased with an increase in %BE for both acids and non-acidic compounds. In contrast, mean cLogP, cLogD7.4, and membrane permeability showed inverse relationship with biliary excretion.
ROC curve analysis was performed to determine the relationships and define the cutoff values for some common physicochemical properties (Table 3) . There is a notable MW cut-off at about 400, where 80% of all compounds with %BE<10 are below this threshold value (true negatives). However, only 62% of all compounds with MW≥400 showed %BE≥10 (true positives 400, however, the true negatives for acids were reduced to 70%. Similarly, ROC curve AUC with permeability and PSA was above 0.8, but the sensitivity or specificity was lower than 80%
at a given cut-off value. Collectively, any single descriptor may not be good enough to predict rat biliary excretion of compounds in this dataset.
Trends for biliary clearance suggested that only MW and Andrews' binding energy are important determinants for both acidic and non-acidic compounds ( Figure 2B ). Although no significant relationship was observed for non-acids, number of rotatable bonds showed a positive trend with biliary clearance for acids. Also, lipophilicity and polar descriptors showed no significant (p>0.05) relationship with biliary clearance for acids.
Scatter plots of MW versus cLogD7.4 show a more defined space for rat biliary excretion (Fig. 3A) . Notably, compounds excreted in bile (%BE≥10) populated the lower right quadrant with a tendency toward higher MW and lower lipophilicity. With MW cut-off at 400 and an arbitrary cLogD7.4 cut-off at 2.0, derived from ROC analysis ( and high permeability compounds showed biliary excretion (Fig. 3C ).
Physicochemical space of hOATPs and rOatp1b2 transporters substrates
This article has not been copyedited and formatted. The final version may differ from this version. From an analysis of 219 diverse compounds with hOATPs substrate data (Supplemental Fig. 4 ).
Scattered plots of MW versus other physicochemical properties show distinct trends (Fig. 4) . While about 75% of hOATP transporters substrates have MW≥400, majority of the substrates have cLogD7.4<2.0 and RPSA≥20%, the arbitrary cut-off values defined based on the ROC analysis of the rat %BE dataset. Similarly, majority of the rOatp1b2 substrates are with MW≥400, cLogD7.4<2.0 and RPSA≥20%. It is interesting to note that the majority of the hOATPs substrates and the rOatp1b2 substrates fall in the space of compounds that showed significant biliary excretion.
Comparison between rat biliary excretion and OATP transporters substrate datasets
In order to understand the similarities between rat %BE and uptake transporters substrate datasets, we performed a Principal Component Analysis (PCA) on the datasets based on six molecular descriptors, which included MW, cLogD7.4, HBA, HBD, RPSA and RB. These properties were picked due to their significant correlation with rat BE (Fig. 2) (Fig. 5) . On the contrary, a number of the compounds with %BE<10 are outside the space occupied by the compounds in the other three datasets.
Although the PCA analysis is rather qualitative, it provides confirmation on the overlapping property space between hepatic sinusoidal uptake and biliary excretion.
In silico models for rat biliary excretion
In evaluating options for building in silico models, numerous approaches were pursuedmultiple linear regressions, continuous and categorical models. Multiple linear regression (QSAR) models for biliary excretion have been reported (Yang et al., 2009; Chen et al., 2010) .
However, the descriptors used varied from model to model and thus, it is unlikely that the equations are transferable from one dataset to another. It is appreciated that biliary excretion is a complex phenomena with involvement of multiple processes. Hence, it seems unlikely that a widely applicable, continuous and quantitative model could be developed. Furthermore, we envision the purpose of an in silico biliary excretion model is to assist research teams in assessing the pursuit of a costly in vivo rat biliary study. Accordingly, we focussed on categorical models with the cut-off at 10% of dose excreted in the bile.
A Gradient Boosting Machine (GBM) model for rat biliary excretion
A binary classification model using a GBM algorithm and 183 MOE descriptors was built and validated via a 5-fold cross validation approach. The breakpoint is set at 10% BE. The results presented in Figure 6a the model can predict whether the compound would have rat biliary excretion of greater or less than 10% with an accuracy of about 80%.
Biliary excretion scoring function
A scoring function based on three determinants, MW, PSA, and acidic pKa, was built.
The breakpoint for the scoring function was determined to be 2.1, meaning that compounds with a score ≥ 2.1 were predicted to have %BE≥10 and vice versa for compounds with a score < 2.1.
Shown in Figure 6b are the results from this scoring function. The positive predictive value was 0.72 (103/143), the negative predictive value was 0.81 (116/143) and the kappa was 0.53. While the predictive and kappa values for this scoring function model are lower than the GBM model, it is nevertheless a good predictive model given that the scoring function is built on three descriptors. Although acidic compounds show a higher propensity to be excreted in the bile, there are compounds in other ionic classes which also have biliary excretion > 10%. The three descriptors used in the scoring function do not adequately capture these compounds. Shown in Figure 7 , are the % correct and incorrect prediction separated by ionic class. For the GBM model, the % correct is uniform across all ionic class (Fig. 7a) . Whereas for the scoring function model, the % correct for bases is only 64% (Fig. 7b ).
Discussion
In vivo studies with the BDC rat model is often used to estimate the %BE during the discovery phase. Here, we analyzed the interrelation of widely used physicochemical properties and rat %BE, and further developed quantitative in silico models to predict biliary excretion.
Physicochemical trends in relation to the rat biliary clearance were also evaluated. Furthermore, we studied the property space of the substrates of human (hOATPs) and rat (rOatp1b2) sinusoidal uptake transporters. Interestingly, significant overlap was noted between the substrates of sinusoidal uptake transporters and the compounds showing considerable biliary excretion (%BE≥10) in rat.
The dominant molecular features for biliary excretion in rat, according to current dataset, are ionization state, MW, lipophilicity and polar descriptors (PSA and RPSA). Higher values in MW, PSA and hydrogen bonding ability are clearly overrepresented among the compounds with significant biliary excretion (%BE≥10), while acidic compounds are predominantly excreted in bile. Furthermore, mean %BE of acids is 2-6 fold higher than that of non-acids (Fig. 1B) . The dataset was thus divided into acids and non-acids and analyzed for relationship between physicochemical properties and %BE. For acids, significant relationship with correlation coefficient above 0.5 was observed for MW, HBA, PSA and Andrew's binding energy; however, such relationships with non-acids yielded relatively low correlation coefficient values ( Table 2 ).
The physicochemical properties associated with extensive rat BE are apparently linked to the low passive membrane permeability (Varma et al., 2010b) . For example, acids are generally ionized at physiological pH (pH 7.4) resulting in low permeability compared to bases, which exist in relatively unionized form. It is also intuitively obvious that the lipophilicity and polar descriptors are positively and inversely related to passive permeability, respectively.
Collectively, trends noted here complement the hypothesis that compounds with high passive
This article has not been copyedited and formatted. The final version may differ from this version. transmembrane transport have an increased potential of redistribution from hepatocytes back to blood and therefore are less likely to be eliminated in bile.
MW has been commonly identified as a physicochemical determinant in several preclinical species and human, where higher MW compounds show a greater propensity for biliary excretion (Millburn et al., 1967a; Millburn et al., 1967b; Wright and Line, 1980; Yang et al., 2009) . With this dataset, we noted that about 84% acids excreted in bile show MW above 400. However, the true negatives for acids were considerably lower than 80%, suggesting that this single descriptor may not be good enough to predict rat biliary excretion bins. Nevertheless, MW , along with PSA and membrane permeability, emerged as distinct features for acids -with significant ROC curve AUC (Table 3) .
Drug in bile is usually more concentrated than in hepatocytes and the plasma, thus passive transport from hepatocytes to bile is expected to be negligible. Consequently, biliary excretion represents an active process involving efflux transporters embedded in the canalicular membrane of hepatocytes. The findings that ionization state, size and polarity are important in the biliary excretion might suggest that these properties are closely associated with molecular interaction with at least the transporters mediating canalicular efflux (MDR1, MRP2, BCRP).
However, the general physicochemical characteristics of the ABC transporters substrates were found to be associated with lipophilicity (Matsson et al., 2009) . The most accepted model of substrate interaction with P-gp suggests ligand partitioning into the plasma membrane before accessing the transporter, thus lipophilicity is proposed to be involved in the initial step of partitioning and membrane accumulation (Varma et al., 2003; Aller et al., 2009) . Similarly, lipophilicity was found to be important for interaction with BCRP, as well as for MRP2 (Gandhi and Morris, 2009; Matsson et al., 2009; Varma et al., 2010a should be noted that drugs with high lipophilicity are also prone to CYP450-mediated metabolism and thus the extent of biliary excretion could be smaller (Obach et al., 2008; Varma et al., 2010b) .
We hypothesized that sinusoidal uptake transports play a determining role in the BE;
and therefore analysized the physicochemical space of hOATPs and rOatp1b2 substrates and compared the general characteristics with rat BE (%BE<10 and %BE≥10) datasets. As evident,
OATPs substrates are predominantly anionic compounds with typically high MW; and the majority of primary physicochemical properties are not significantly different (P>0.05) from the dataset of compounds with %BE≥10 (Table 1 and Fig. 4 ). PCA analysis further confirmed the physicochemical space overlap between the uptake transporter substrates and the %BE≥10 dataset, while unveiling distinct difference from the %BE<10 dataset (Fig. 5 ). rOatp1b2
substrates in the current dataset is confined to a small physicochemical space and significantly overlaps with the hOATPs substrates and %BE≥10 datasets. This significant overlap of the property space of rat and human uptake transporters substrates and rat %BE≥10 dataset suggests predominant role of sinusoidal uptake transporters in biliary elimination. Overall, the physicochemical features of biliary excretion is associated with a balance of limited passive permeability and hepatic metabolism and enhanced interaction with hepatic uptake as well as efflux transporters.
Based on apparent correlation between intestinal permeability and extent of drug metabolism, Benet and coworkers proposed the biopharmaceutics drug disposition classification system (BDDCS) (Wu and Benet, 2005; Benet et al., 2008; Benet, 2009; Benet et al., 2011 ).
Accordingly, the major route of elimination of high-permeability (class I and II) drugs is metabolism, predominantly cytochrome P450-mediated, while the major route of elimination for the poorly permeable (class III and IV) drugs is renal and/or biliary excretion of unchanged drug (Benet et al., 2011; Varma et al., 2012) . This is generally consistent with our observations that , 2009; Gandhi and Morris, 2009; Matsson et al., 2009; Varma et al., 2010a) . However, our analysis using a sizable dataset showed that hOATPs and rOatp1b2 substrates tend toward large MW (Table 1 and Fig. 4) . Previously, using a dataset of human renal clearance for 391 compounds, we observed that the bases dominate the list of compounds secreted in urine (46%), with acids accounting for only 31% (Varma et al., 2009) . A rather predominant presence of acids in the %BE≥10 subset (Fig. 1C) suggests that the substrate specificity of OATPs, which noticeable transports acids with high MW, may primarily define the elimination route (renal Vs biliary excretion). Nevertheless, there are exceptions to these general observations. For example, quaternary ammonium compounds (MW<300Da) are extensively excreted in bile and their hepato-biliary transport is known to be mediated by OCT1 and P-gp (Song et al., 2010) .
Compounds taken up by the hepatocytes might undergo excretion into bile, however, the rate-determining step could be either transport across the sinusoidal membrane or the canalicular membrane. The overlapping physicochemical space between the datasets of biliary excretion (%BE≥10) and the OATP transporters substrates confer several premises. Firstly, physicochemical properties responsible for interaction with canalicular efflux transporters are at least partially similar to that of sinusoidal uptake OATP transporters. Secondly, active hepatic uptake via OATPs or other sinusoidal uptake transporters is a prerequisite for a compound to be eliminated significantly in bile. Finally, sinusoidal active uptake clearance may be rate-limiting step for biliary clearance of compounds with significant biliary excretion.
While scatter plots of physicochemical properties and BE show strong trends for those compounds that reside in particular quadrants, they are less predictive for compounds in the other two quadrants (Fig. 3) . Consequently, more comprehensive in silico models were pursued.
Although QSAR models for biliary excretion with smaller datasets have been published (Yang et al., 2009; Chen et al., 2010) , using our large collection of rat biliary excretion dataset, we were unable to obtain a meaningful QSAR model when limiting the number of 2D and physicochemical descriptors to 10 or less. For example, the most convincing QSAR model we arrived at for acids (based on a set of five 2D molecular operating environment descriptors (Chemical Computing Group, Canada) and ACD physicochemical descriptors (Advanced Chemistry Development, Canada) using JMP 9.0.1. (SAS, Cary, NC) for step-wise analysis), resulted in correlation coefficient of only 0.58 (data not shown). Although, further approaches using 3D-descriptors may help establish improved models, due to the complexity and multiplicity of processes involved in determining the extent of biliary excretion, it is likely that the predictability of quantitative models based on few 2D descriptors is limited. However, two accurate qualitative computational models for the prediction of biliary excretion were developed -a classification model and a novel scoring function. The GBM model was able to correctly classify %BE<10 or %BE≥10 categories for a test set with an accuracy of about 80% for both categories (Fig. 6A) . Additionally, an easily interpretable scoring function that uses only three descriptors (MW, PSA and acidic pKa) was generated (Fig. 6B) . This model correctly classified %BE<10 or %BE≥10 with an accuracy of 81% and 72%, respectively. This scoring function model has the advantage of being more transparent than the GBM model. The predictability of the latter rules-of-thumb model may be valuable for rapid interpretation in the early drug discovery settings.
This article has not been copyedited and formatted. The final version may differ from this version. Biliary excretion often contributes more to the elimination of drugs in rat than in human, possibly due to the higher expression levels of the hepato-biliary transporters and high bile flow of rats (Lai, 2009) . Based on the emerging absolute protein quantification data, MRP2, BCRP and BSEP are relatively highly expressed in rat compared to human. While, we note the importance of sinusoidal uptake transports in biliary clearance, species differences in the expression of major sinusoidal uptake transports may also contribute to the differences in biliary excretion and clearance. Although, the species differences need further investigation, analyzing 
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